Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors

CT Supuran - Journal of Experimental Pharmacology, 2020 - Taylor & Francis
Abstract Carbonic anhydrase (CA, EC 4.2. 1.1) isoforms IX and XII are overexpressed in
many hypoxic tumors as a consequence of the hypoxia inducible factor (HIF) activation …

Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)

A Nocentini, CT Supuran - Expert Opinion on Therapeutic Patents, 2018 - Taylor & Francis
Introduction: Human carbonic anhydrases (CA, EC 4.2. 1.1) IX and XII are tumor-associated
proteins, being part of the molecular machinery that tumor cells build as adaptive responses …

Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII

OO Guler, GD Simone… - Current medicinal …, 2010 - ingentaconnect.com
The carbonic anhydrase (CA, EC 4.2. 1.1) isozymes IX and XII are predominantly found in
tumor cells and show a restricted expression in normal tissues. By efficiently hydrating …

Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors

CT Supuran - Expert opinion on investigational drugs, 2018 - Taylor & Francis
Introduction: Hypoxic tumors overexpress two carbonic anhydrases (CA, EC 4.2. 1.1), CA IX
and XII, involved in complex processes connected to tumorigenesis (pH regulation …

Carbonic anhydrase IX inhibitors in cancer therapy: an update

CT Supuran, JY Winum - Future medicinal chemistry, 2015 - Taylor & Francis
Carbonic anhydrases (CAs; EC 4.2. 1.1) are well known zinc metalloproteins involved in the
catalysis of a very simple but essential physiological reaction: carbon dioxide hydration to …

Targeting tumor-associated carbonic anhydrase IX in cancer therapy

A Thiry, JM Dogne, B Masereel, CT Supuran - Trends in pharmacological …, 2006 - cell.com
Carbonic anhydrase isoform IX (CA IX) is highly overexpressed in many types of cancer. Its
expression, which is regulated by the HIF-1 transcription factor, is strongly induced by …

Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors

CT Supuran - Expert Opinion on Investigational Drugs, 2021 - Taylor & Francis
Introduction Hypoxic tumors, unlike normal tissues, overexpress proteins involved in oxygen
sensing, metabolism, pH regulation, angiogenesis, immunological response, and other …

Carbonic anhydrase IX: a new druggable target for the design of antitumor agents

JY Winum, M Rami, A Scozzafava… - Medicinal research …, 2008 - Wiley Online Library
Abstract Carbonic anhydrases (CAs, EC 4.2. 1.1) are a family of enzymes widespread in all
life kingdoms. In mammals, isozyme CA IX is highly overexpressed in many cancer types …

Carbonic anhydrase inhibitors and the management of cancer

S Pastorekova, J Kopacek… - Current topics in medicinal …, 2007 - ingentaconnect.com
Recent progress in understanding the role of catalytically active carbonic anhydrases in
tumors has opened new possibilities for diagnostic and/or therapeutic applications of …

[HTML][HTML] Recent developments in targeting carbonic anhydrase IX for cancer therapeutics

PC McDonald, JY Winum, CT Supuran, S Dedhar - Oncotarget, 2012 - ncbi.nlm.nih.gov
Carbonic anhydrase IX (CAIX) is a hypoxia-inducible enzyme that is overexpressed by
cancer cells from many tumor types, and is a component of the pH regulatory system …